COVID-19 nanoMIP

The MIP Discovery COVID-19 nanoMIP is a synthetic alternative to SARS-CoV-2 antibodies that offers ultra-high sensitivity for the next wave of COVID-19 antigen detecting sensors. Following thorough testing, the nanoMIP has demonstrated an extremely low limit of detection of 5 fg/ml to the RBD spike protein in a sensor device. This is a 20 fold improvement to antibodies when tested side-by-side!

Alongside this exceptional sensitivity performance, COVID-19 nanoMIPs also enable simple and successful integration into sensor platforms when compared with natural receptors such as SARS-CoV-2 antibodies or nucleic acids. nanoMIPs easily couple to the solid surface of an electrode whereas natural receptors will deform or denature during the coupling process.